Completely updated and revised, the 32nd edition of this best-selling reference delivers the latest evidence-based recommendations for the treatment of infectious diseases in children. Each disease is accompanied by expert commentary, helping clinicians choose the best antimicrobial options based on current research and clinical experience. It includes detailed descriptions of all antimicrobial agents available today, with complete dosing regimens. New in the 32nd EditionThis edition is fully reviewed for updates, and references are updated throughout the book. Highlights of updated or new guidelines includeChapter 5, "Preferred Therapy for Specific Fungal Pathogens": update to candidiasis therapy for systemic infectionsChapter 6, "Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins": dosage updates for posaconazole and isavuconazoleChapter 15, "Antimicrobial Prophylaxis/Prevention of Symptomatic Infection": updates toTable A, "Postexposure Antimicrobial Prophylaxis to Prevent Infection": tuberculosis, neonatal herpes simplex virusTable C, "Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection": new information for recurrent mucocutaneous herpes simplex virusTable D, "Surgical Procedure Prophylaxis": intraoperative Re-Dosing interval (h) for prolonged surgery updated throughout; piperacillin/tazobactam therapy added for complicated appendicitis or other ruptured colorectal viscusChapter 18, Table A, "Systemic Antimicrobials With Dosage Forms and Usual Dosages": now includesCeftobiprole medocaril sodium, ZevteraGeptotidacin, BlujepaMinocycline ER, EmrosiParomomycin, Humatin

Completely updated and revised, the 32nd edition of this best-selling reference delivers the latest evidence-based recommendations for the treatment of infectious diseases in children. Each disease is accompanied by expert commentary, helping clinicians choose the best antimicrobial options based on current research and clinical experience. It includes detailed descriptions of all antimicrobial agents available today, with complete dosing regimens. New in the 32nd EditionThis edition is fully reviewed for updates, and references are updated throughout the book. Highlights of updated or new guidelines includeChapter 5, "Preferred Therapy for Specific Fungal Pathogens": update to candidiasis therapy for systemic infectionsChapter 6, "Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins": dosage updates for posaconazole and isavuconazoleChapter 15, "Antimicrobial Prophylaxis/Prevention of Symptomatic Infection": updates toTable A, "Postexposure Antimicrobial Prophylaxis to Prevent Infection": tuberculosis, neonatal herpes simplex virusTable C, "Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection": new information for recurrent mucocutaneous herpes simplex virusTable D, "Surgical Procedure Prophylaxis": intraoperative Re-Dosing interval (h) for prolonged surgery updated throughout; piperacillin/tazobactam therapy added for complicated appendicitis or other ruptured colorectal viscusChapter 18, Table A, "Systemic Antimicrobials With Dosage Forms and Usual Dosages": now includesCeftobiprole medocaril sodium, ZevteraGeptotidacin, BlujepaMinocycline ER, EmrosiParomomycin, Humatin